Please provide your email address to receive an email when new articles are posted on . Combining pegloticase with immunomodulation therapy greatly improves pegloticase response rates in patients with ...
Please provide your email address to receive an email when new articles are posted on . The points to consider advise beginning immunomodulatory therapy while diagnostic investigations continue.
Created with Figdraw. The downward arrow indicates a decrease in content. The solid arrow represents “direct action”, with a clear path of influence; the dashed arrow indicates “indirect action”, ...
Radiotherapy with concurrent Avelumab and Cetuximab as primary treatment in patients with locally advanced squamous cell carcinoma of the head and neck: A phase-IB feasibility trial in patients unfit ...
A prospective multicenter phase II study of sorafenib combined with cisplatin plus gemcitabine for the treatment of patients with advanced renal collecting duct carcinoma (NCT01762150). This is an ...